Furthermore, the identification of genes associated with heart failure that are downregulated by Atenolol (such as Junb, Klf2, Alas2, and Rarres2) demonstrates the underlying molecular changes responsible for improved heart function, which may lead to new downstream targets for treating heart failure. Here, KLF2 is linked to heart failure.